Structure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.

Open	$27.15
Close	$27.06
Volume / Avg.	846.85K / 844.29K
Day Range	$26.50 - $27.45
52 Wk Range	23.50 - 62.74
Market Cap	$1.57B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	22.28%
Days to Cover	10.22

Recent News

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Vandana Singh

Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.15
Close	$27.06
Volume / Avg.	846.85K / 844.29K
Day Range	$26.50 - $27.45
52 Wk Range	23.50 - 62.74
Market Cap	$1.57B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	22.28%
Days to Cover	10.22

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Structure Therapeutics (GPCR) stock?

You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.

View our list of the best stock brokerages

Who are Structure Therapeutics (GPCR) competitors?

Other companies in Structure Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Ocular Therapeutix (NASDAQ:OCUL).

What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?

Structure Therapeutics has a consensus price target of $75.55.

What is the current price for Structure Therapeutics (GPCR)?

The stock price for Structure Therapeutics (NASDAQ: GPCR) is $27.39 last updated January 17, 2025 at 5:16 PM EST.

Does Structure Therapeutics (GPCR) pay a dividend?

There are no upcoming dividends for Structure Therapeutics.

When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?

Structure Therapeutics’s Q4 earnings are confirmed for Friday, March 7, 2025.

Is Structure Therapeutics (GPCR) going to split?

There is no upcoming split for Structure Therapeutics.

What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Structure Therapeutics

Structure Therapeutics (GPCR) Forecast